EDGARDO OJEDA ARCE: Open Payments
NPI 1568877975 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 9 payments from 7 companies in 2025. Trend: 2023 $672 · 2024 $806 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $115 |
| Corium, LLC | 3 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
Products named: COBENFY, Azstarys, REXULTI, VRAYLAR, Auvelity, INGREZZA, Ozempic.
Industry payments across TX — which companies pay providers there.
